Zenas BioPharma, Inc. Common Stock (ZBIO) — Long-term Investment Intensity
Zenas BioPharma, Inc. Common Stock (ZBIO) has a Long-term Investment Intensity of 0.2% as of March 2026. Long-term investments of $1.34 Million represent 0.2% of total assets of $747.68 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Zenas BioPharma, Inc. Common Stock investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Zenas BioPharma, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how Zenas BioPharma, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the intensity stands at 0.2%, reflecting long-term investments of $1.34 Million against total assets of $747.68 Million USD. Explore ZBIO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Zenas BioPharma, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Zenas BioPharma, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ZBIO market cap.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 4.5% | $17.27 Million | $383.64 Million | — |